NeuroVive Pharmaceutical | Date: 2015-03-04
The present invention relates to cyclosporine emulsions containing: (i) a cyclosporine, (ii) a natural oil (long chain triglyceride), (iii) a phosphatidylcholine, (iv) glycerol, (v) a pharmaceutically tolerable alkali salt of a free fatty acid, (vi) a medium chain triglyceride-oil, (vii) optionally, hydrochloric acid or sodium hydroxide for pH adjustment and (viii) water, and to therapeutic methods using them.
NeuroVive Pharmaceutical and Neuropharma I Sverige Ab | Date: 2008-10-28
Pharmaceutical and veterinary preparations, namely, medicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; medicines and pharmaceutical preparations for neurosurgical conditions, brain damage and brain operations; pharmaceutical preparations for use within the area of neurological intensive care; pharmaceutical preparations for use as immunosuppressive agents.
NeuroVive Pharmaceutical | Date: 2012-02-29
Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions.
NeuroVive Pharmaceutical | Date: 2011-12-20
There are provided inter alia compounds of formula (I) and (II) and their use in therapy, particularly for the treatment of viral infection.
NeuroVive Pharmaceutical | Date: 2012-10-24
There is provided inter alia a pharmaceutical dosage form for oral administration comprising a sanglifehrin as active ingredient in which the sanglifehrin active ingredient is protected from acid degradation in the stomach environment following oral administration.